OA is the most common chronic condition affecting 80% of senior dogs at the moment. Most treatment options strive to manage pain and mobility and slow OA progression.  New research is surfacing in emerging therapies that we hope will lead to the regeneration of tissues, not just management.   OA is often categorised as cartilage degeneration, but in more recent years, the aspect of inflammation of the whole joint, including the synovium, has been taken into account when thinking about how to...

Beyond that, several high‑quality clinical trials have evaluated how these marine‑based fatty acids stack up against NSAIDs, glucosamine, and other joint supplements. This blog breaks down the science in a clear, practical way so you can make informed decisions for your dog’s joint health. 🟢 Mussel Powder vs Antinol: Why the Extraction Method Matters Although both products originate from New Zealand green‑lipped mussels, the way they’re processed leads to major differences in safety,...

On the 26th September 2025 I was lucky enough to be able to attend the NAVP conference which covered a whole host of interesting lectures.  If you want to take a peek into my day at the conference you can watch that video here- https://youtu.be/DVq7mN6wUBA   In this blog I am going to attempt to summarise 6 lectures in a way that makes them easy for you to understand.  They were all super interesting and if you want more information about any of them please feel free to reach out for a...